Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Invasive Prostate Carcinoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Invasive Malignant Neoplasm
Invasive Carcinoma
Invasive Prostate Carcinoma

Subtype

Invasive Prostate Carcinoma

CI-CAN-00002961Explore in graph →

139 active trials1 approved drugs3 evidence items

NCIt: C48596

Overview
Statistics
Survival
Genomics26
Variants & evidence3
Drugs3
Trials440
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

440 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 139
Recruiting: 65
Ph III recruiting: 5
Growth YoY: —
Industry share: 4%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 31.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (72)

StatusAll Active (any)Completed 181 Recruiting 74 Active Not Recruiting 72 Terminated 56 Unknown 25 Withdrawn 19 Not Yet Recruiting 6 Suspended 3 No Longer Available 3 Approved For Marketing 1

PhaseAll Early Phase 1 6 N/A 84 Phase 1 74 Phase 2 226 Phase 3 39 Phase 4 3

No study matches these filters